Medical aesthetics company Laboratories FILLMED hosted its Summer Symposium on June 6 at the Fitzroy Hotel, London.
Speakers included Dr Ash Labib, Dr Lisa Dinley, Dr Raquel Amado, Mr Amar Ghattaura, Dr Baldeep Farmah, Dr Tim Eldridge and Poppy Pilram, who shared their own treatment approaches, clinical outcomes and product layering. JUVELOOK, a regenerative hybrid dermal biostimulator, joins FILLMED’s established range of injectables and skincare solutions, including NCTF 135HA, ART FILLER and the SKIN PERFUSION line.
The collaboration signals an expansion of the brand’s multi-modal approach to skin quality, offering practitioners a new tool to support dermal remodelling and rejuvenation, the company explains.
Scott Julian, Laboratories FILLMED business unit director UK&I, commented, “Our latest collaboration with JUVELOOK is one of our most exciting and ground-breaking collaborations to date. As part of this exciting alliance, co-branded FILLMED x Juvelook packaging will go into production at the end of 2025, signalling a long-term commitment to innovation, clinical excellence and synergy between both brands.”
